https://www.fiercepharma.com/pharma/roche-eyes-year-end-lunsumio-fda-verdict-be-first-bispecific-non-hodgkin-lymphoma
ʂ̃TCgɃWv悤ƂĂ܂BXΏL̃NNbNĂ
UPLIFTōLȂő̌܂傤IKȉ{Ct܂I